PD-1 checkpoint blockade in advanced melanoma patients: NK cells, monocytic subsets and host PD-L1 expression as predictive biomarker candidates

Blockade of the PD-1 receptor has revolutionized the treatment of metastatic melanoma, with significant increases in overall survival (OS) and a dramatic improvement in patient quality of life. Despite the success of this approach, the number of benefitting patients is limited and there is a need fo...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yago Pico de Coaña, Maria Wolodarski, Irene van der Haar Àvila, Takahiro Nakajima, Stamatina Rentouli, Andreas Lundqvist, Giuseppe Masucci, Johan Hansson, Rolf Kiessling
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2020-01-01
Edice:	OncoImmunology
Témata:	melanoma immune checkpoint inhibitors mdscs nk cells predictive biomarkers
On-line přístup:	http://dx.doi.org/10.1080/2162402X.2020.1786888
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!